Since its introduction to the market in 2012, Unyvero has been brought into numerous hospital laboratories and intensive care units throughout Europe. Leading clinical experts have tested the system and now appreciate the advantages of the Unyvero Solution in everyday clinical use.
Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test
Curetis Group: Ares Genetics Receives Funding Commitment For EUR 1.6 Mio. Project; Curetis Announces Non-Audited Financial Results for 2017
28. Symposium Intensivmedizin + Intensivpflege - Bremen, Germany - 14 to 16 February, 2018
70th Annual Meeting of the German Society for Hygiene and Microbiology (DGHM), Bochum, Germany - February 19 to 21, 2018